Dr. Wilkerson has consistently been the "go to” development executive for the most challenging projects in pipeline. Dr. Wilkerson provides interpretation, guidance, and advice on clinical development plans, clinical study design, and regulatory issues; and ensures on time implementation and delivery. Dr. Wilkerson’s industry experience has been primarily focused in clinical operations, overlapping with regulatory affairs (RAC certified in 2003), drug packaging and labeling, product development/marketing, data management, and pharmacovigilance. She holds her PhD in Biochemistry from the Stanford University School of Medicine, where she was a National Science Foundation Pre-Doctoral Fellow.